Skip to content

Physical and Cognitive Performance in Older Adults With Fatigue

Physical and Cognitive Performance in Older Adults With Fatigue

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06509620
Enrollment
70
Registered
2024-07-19
Start date
2024-08-01
Completion date
2025-05-01
Last updated
2024-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue

Keywords

fatigue, older adult

Brief summary

Fatigue is a common symptom in older adults, often linked to various medical conditions, medications, and psychosocial factors, and it can adversely affect both physical and cognitive performance in the aging population, contributing to functional decline and reduced quality of life. Assessment of the physical impact of fatigue on physical and cognitive performance in older adults can offer valuable insights for clinical practice and holistic geriatric care. Therefore, this study will validate subjective tools used for measuring the impact of fatigue against objective measures.

Interventions

fatigue severity scale is a unidimensional, nine-item questionnaire capturing information on the impact and severity of fatigue. Participants rated the 9-items on a 7-point, Likert-type scale with anchors of strongly disagree (1) and strongly agree (7) based on the previous week. The overall score is an average of the individual item scores and can range between 1 and 7.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participants aged 60 years old and above both males and females

Exclusion criteria

* o Patients with acute medical illness. * Patients with life threatening illnesses. * Bedridden patients. * Patients with diagnosed malignancy. * Patients with debilitating chronic disease (end organ failure) (e.g. heart failure , renal failure, and liver cell failure). * Patients with neurological diseases (e.g. moderate to severe dementia, stroke, parkinsonism) that interfere with the assessment process. * Patients with musculoskeletal conditions that interfere with the assessment process (fracture, disabling osteoarthritis, painful arthritis). * Patients with severe uncorrected hearing loss, vision impairment, or aphasia that may impede effective communication during the assessment.

Design outcomes

Primary

MeasureTime frameDescription
The primary outcome measure the difference in cognitive performance between older adults with and without fatigue, assessed using the Montreal Cognitive Assessment (MoCA)6 monthscompare the MoCA scores between the fatigued and non-fatigued groups using appropriate statistical methods (e.g., t-tests or ANCOVA adjusting for potential confounders). MOCA score is 30 with 18-25 = mild cognitive impairment, - 10-17= moderate cognitive impairment and - less than 10= severe cognitive impairment.
The primary outcome measure the difference in physical performance between older individuals with and without fatigue, assessed using 6 minutes walk test6 monthsThe primary outcome will compare the 6 minutes walk test between the fatigued and non-fatigued groups using appropriate statistical methods (e.g., t-tests or ANCOVA adjusting for potential confounders).

Countries

Egypt

Contacts

Primary ContactDoha Rasheedy, MD
doharasheedy@med.asu.edu.eg01001193544

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026